20 companies

Aurobindo Pharma

Market Cap: ₹673.0b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

AUROPHARMA

₹1,150.60

7D

-2.9%

1Y

4.4%

Sun Pharmaceutical Industries

Market Cap: ₹4.1t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

SUNPHARMA

₹1,732.30

7D

1.9%

1Y

5.7%

Alkem Laboratories

Market Cap: ₹644.7b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

ALKEM

₹5,490.50

7D

0.2%

1Y

19.1%

Cipla

Market Cap: ₹1.1t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

CIPLA

₹1,326.50

7D

-2.2%

1Y

-10.2%

Abbott India

Market Cap: ₹558.1b

Operates as a pharmaceutical company in India.

500488

₹26,478.15

7D

0.6%

1Y

-11.2%

Emcure Pharmaceuticals

Market Cap: ₹272.6b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

EMCURE

₹1,435.60

7D

-2.4%

1Y

46.5%

Zydus Lifesciences

Market Cap: ₹906.4b

Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

ZYDUSLIFE

₹907.95

7D

-0.3%

1Y

1.9%

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹321.3b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

506943

₹2,047.20

7D

3.5%

1Y

30.4%

Glenmark Pharmaceuticals

Market Cap: ₹576.6b

Develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally.

GLENMARK

₹2,039.20

7D

0.4%

1Y

53.9%

Torrent Pharmaceuticals

Market Cap: ₹1.4t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

500420

₹4,311.65

7D

1.2%

1Y

43.2%

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹440.5b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

500660

₹2,637.35

7D

1.5%

1Y

0.2%

Pfizer

Market Cap: ₹225.6b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

PFIZER

₹5,071.50

7D

1.1%

1Y

21.0%

Sai Life Sciences

Market Cap: ₹199.2b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

SAILIFE

₹968.10

7D

5.2%

1Y

39.0%

Ajanta Pharma

Market Cap: ₹367.1b

A pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages.

AJANTPHARM

₹2,978.40

7D

1.3%

1Y

16.1%

Anthem Biosciences

Market Cap: ₹383.0b

Operates as technology-focused contract research, development, and manufacturing organization.

ANTHEM

₹696.35

7D

0.9%

1Y

n/a

Divi's Laboratories

Market Cap: ₹1.7t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

DIVISLAB

₹6,293.50

7D

2.3%

1Y

10.4%

Lupin

Market Cap: ₹1.0t

Operates as a pharmaceutical company in India, the United States, and internationally.

500257

₹2,245.10

7D

1.1%

1Y

18.0%

Ipca Laboratories

Market Cap: ₹367.8b

An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia.

IPCALAB

₹1,473.70

7D

-1.4%

1Y

2.4%

Dr. Reddy's Laboratories

Market Cap: ₹1.1t

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

500124

₹1,307.00

7D

3.0%

1Y

12.2%

Gland Pharma

Market Cap: ₹300.1b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.

GLAND

₹1,802.80

7D

-0.3%

1Y

18.2%